The regulation and role of osteopontin in malignant transformation and cancer

被引:175
作者
El-Tanani, Mohamed K.
Campbell, Frederick Charles
Kurisetty, Vittal
Jin, Dachuan
McCann, Mella
Rudland, Philip S.
机构
[1] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT9 7AB, Antrim, North Ireland
[2] Univ Liverpool, Sch Biol Sci, Canc & Polio Res Fund Labs, Liverpool L69 7ZB, Merseyside, England
关键词
osteopontin; transcription regulators; cancer; metastasis;
D O I
10.1016/j.cytogfr.2006.09.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Osteopontin (OPN) is a predominantly secreted extracellular matrix glycophosphoprotein which binds to alpha v-containing integrins and has an important role in malignant cell attachment and invasion. High OPN expression in the primary tumor is associated with early metastasis and poor outcome in human breast and other cancers. Forced OPN overexpression in benign cells may induce neoplastic-like cell behaviour including increased attachment and invasion in vitro as well as the ability to metastasize in vivo. Conversely, OPN inhibition by antisense cDNA impedes cell growth and tumor forming capacity. OPN is not mutationally activated in cancer but its expression is regulated by Wnt/Tcf signaling, steroid receptors, growth factors, ras, Ets and AP-1 transcription factors. Presumably these factors are implicated in induction of OPN overexpression in cancer. Greater understanding of the role of OPN in neoplastic change and its transcriptional regulation may enable development of novel cancer treatment strategies. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:463 / 474
页数:12
相关论文
共 75 条
[1]  
Agrawal D, 2002, J NATL CANCER I, V94, P513
[2]   Phosphorylated osteopontin promotes migration of human choriocarcinoma cells via a p70 S6 kinase-dependent pathway [J].
Al-Shami, R ;
Sorensen, ES ;
Ek-Rylander, B ;
Andersson, G ;
Carson, DD ;
Farach-Carson, MC .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2005, 94 (06) :1218-1233
[3]   Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells [J].
Angelucci, A ;
Festuccia, C ;
Gravina, GL ;
Muzi, P ;
Bonghi, L ;
Vicentini, C ;
Bologna, M .
PROSTATE, 2004, 59 (02) :157-166
[4]  
BELLAHCENE A, 1995, AM J PATHOL, V146, P95
[5]   Osteopontin transcription in aortic vascular smooth muscle cells is controlled by glucose-regulated upstream stimulatory factor and activator protein-1 activities [J].
Bidder, M ;
Shao, JS ;
Charlton-Kachigian, N ;
Loewy, AP ;
Semenkovich, CF ;
Towler, DA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (46) :44485-44496
[6]   Antiproliferative effects of 1,25-dihydroxyvitamin D3 on breast cells -: A mini review [J].
Bortman, P ;
Folgueira, MAAK ;
Katayama, MLH ;
Snitcovsky, IML ;
Brentani, MM .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2002, 35 (01) :1-9
[7]   Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer [J].
Brakora, KA ;
Lee, H ;
Yusuf, R ;
Sullivan, L ;
Harris, A ;
Colella, T ;
Seiden, MV .
GYNECOLOGIC ONCOLOGY, 2004, 93 (02) :361-365
[8]   Serial plasma osteopontin levels have prognostic value in metastatic breast cancer [J].
Bramwell, Vivien H. C. ;
Doig, Gordon S. ;
Tuck, Alan B. ;
Wilson, Sylvia M. ;
Tonkin, Katia S. ;
Tomiak, Anna ;
Perera, Francisco ;
Vandenberg, Theodore A. ;
Chambers, Ann F. .
CLINICAL CANCER RESEARCH, 2006, 12 (11) :3337-3343
[9]  
BROWN LF, 1994, AM J PATHOL, V145, P610
[10]   Osteopontin induction is required for tumor promoter-induced transformation of preneoplastic mouse cells [J].
Chang, PL ;
Cao, MT ;
Hicks, P .
CARCINOGENESIS, 2003, 24 (11) :1749-1758